Skip to content

Screener

Eligibility screening

Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Sponsored by Organon and CoStudy detailsClinicalTrials.gov

38 US sites in AL, AR, CA, CO +20

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.